Page 304 - Vitamin D and Cancer

12 The Vitamin D Signaling Pathway in Mammary Gland and Breast Cancer 291

13. Garland CF, Gorham ED, Mohr SB et al (2007) Vitamin D and prevention of breast cancer:
pooled analysis. J Steroid Biochem Mol Biol 103:708–711
14. Glerup H, Mikkelsen K, Poulsen L et al (2000) Commonly recommended daily intake of
vitamin D is not sufficient if sunlight exposure is limited. J Intern Med 247:260–268
15. Bodnar LM, Simhan HN, Powers RW et al (2007) High prevalence of vitamin D insufficiency
in black and white pregnant women residing in the northern United States and their neonates.
J Nutr 137:447–452
16. Gonzalez G, Alvarado JN, Rojas A et al (2007) High prevalence of vitamin D deficiency in
Chilean healthy postmenopausal women with normal sun exposure: additional evidence for a
worldwide concern. Menopause 14:455–461
17. Siddiqui AM, Kamfar HZ (2007) Prevalence of vitamin D deficiency rickets in adolescent
school girls in Western region, Saudi Arabia. Saudi Med J 28:441–444
18. Vieth R, Bischoff-Ferrari H, Boucher BJ et al (2007) The urgent need to recommend an intake
of vitamin D that is effective. Am J Clin Nutr 85:649–650
19. Lappe JM, Travers-Gustafson D, Davies KM et al (2007) Vitamin D and calcium supplemen-
tation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 85:1586–1591
20. Bouillon R, Eelen G, Verlinden L et al (2006) Vitamin D and cancer. Steroid Biochem Mol
Biol 102:156–162
21. Deeb KK, Trump DL, Johnson CS (2007) Vitamin D signalling pathways in cancer: potential
for anticancer therapeutics. Nat Rev Cancer 7:684–700
22. Valrance ME, Brunet AH, Acosta A et al (2007) Dissociation of growth arrest and CYP24
induction by VDR ligands in mammary tumor cells. J Cell Biochem 101:1505–1519
23. Zinser GM, McEleney K, Welsh JE (2003) Characterization of mammary tumor cell lines
from wild type and vitamin D(3) receptor knockout mice. Mol Cell Endocrinol 200:67–80
24. Byrne B, Welsh JE (2007) Identification of novel mediators of vitamin D signaling and 1,
25(OH)2D3 resistance in mammary cells. J Steroid Biochem Mol Biol 103:703–707
25. Swami S, Raghavachari N, Muller UR et al (2003) Vitamin D growth inhibition of breast
cancer cells: gene expression patterns assessed by cDNA microarray. Breast Cancer Res Treat
80:49–62
26. Towsend K, Trevino V, Falciani F et al (2006) Identification of VDR-responsive gene signa-
tures in breast cancer cells. Oncology 71:111–123
27. Cordero JB, Cozzolino M, Lu Y et al (2002) 1, 25-Dihydroxyvitamin D down-regulates cell
membrane growth- and nuclear growth-promoting signals by the epidermal growth factor
receptor. J Biol Chem 277:38965–38971
28. Kawata H, Kamiakito T, Takayashiki N et al (2006) Vitamin D3 suppresses the androgen-
stimulated growth of mouse mammary carcinoma SC-3 cells by transcriptional repression of
fibroblast growth factor 8. J Cell Physiol 207:793–799
29. Wu Y, Craig TA, Lutz WH et al (1999) Identification of 1 alpha, 25-dihydroxyvitamin D3
response elements in the human transforming growth factor beta 2 gene. Biochemistry
38:2654–2660
30. Lazzaro G, Agadir A, Qing W et al (2000) Induction of differentiation by 1alpha-hydroxyvi-
tamin D(5) in T47D human breast cancer cells and its interaction with vitamin D receptors.
Eur J Cancer 36:780–786
31. Pendas-Franco N, Gonzalez-Sancho JM, Suarez Y et al (2007) Vitamin D regulates the
phenotype of human breast cancer cells. Differentiation 75:193–207
32. Mathiasen IS, Lademann U, Jaattela M (1999) Apoptosis induced by vitamin D compounds
in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53. Cancer
Res 59:4848–4856
33. Narvaez CJ, Welsh J (2001) Role of mitochondria and caspases in vitamin D-mediated
apoptosis of MCF-7 breast cancer cells. J Biol Chem 276:9101–9107
34. Mathiasen IS, Sergeev IN, Bastholm L et al (2002) Calcium and calpain as key mediators of
apoptosis-like death induced by vitamin D compounds in breast cancer cells. J Biol Chem
277:30738–30745